Estee Lauder Companies Inc vs Smith & Nephew plc — how do they compare? Estee Lauder Companies Inc trades at $88 (market cap $31.76B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: Estee Lauder Companies Inc is far larger — about 2.5× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.65%). Which is the better fit depends on your goals.
| EL | SNN | |
|---|---|---|
Market Cap | $31.76B | $12.54B |
Sector | Consumer Staples | Health |
52-Week High | $119.61 | $38.70 |
52-Week Low | $67.23 | $28.73 |
Enterprise Value | $37.93B | $15.57B |
Dividend Yield | 1.59% | 2.65% |
Trailing returns across standard periods
Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Read more on EL →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →